您的位置: 首页 > 农业专利 > 详情页

treatment of genotyped diabetic patients with dpp-lv inhibitors such as linagliptin
专利权人:
Boehringer Ingelheim International Gmbh
发明人:
Eva Ulrike Graefe-Mody,Hans-Juergen Woerle,Heike Zimdahl-Gelling,Klaus Dugi,Michael Mark
申请号:
BR112012012641
公开号:
BR112012012641A2
申请日:
2010.11.26
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
use of the ddp-4 inhibitor, pharmaceutical composition or combination thereof, in the preparation of medicines for the treatment of diabetes and kit of parts. the present invention relates to methods for preventing or treating metabolic disorders and related conditions, such as in certain patient groups.uso do inibidor ddp-4, composição ou combinação farmacêutica do mesmo, no preparo de medicamentos para o tratamento de diabetes e kit de partes. a presente invenção se refere a métodos para prevenir ou tratar de distúrbios metabólicos e condições relacionadas, tais como, em certos grupos de paciente.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充